138 related articles for article (PubMed ID: 31157576)
1. Development of the Psoriasis Symptoms Scale (PSS) in patients with moderate-to-severe psoriasis: qualitative and quantitative analyses.
Armstrong AW; Edson-Heredia E; Naegeli AN; Burge R; Poon JL; Anatchkova M; Sun L; Zhu B; Wyrwich KW
J Dermatolog Treat; 2020 Aug; 31(5):452-459. PubMed ID: 31157576
[No Abstract] [Full Text] [Related]
2. Reliability, validity, and the ability to detect change of the Psoriasis Symptom Scale (PSS) in patients with plaque psoriasis.
Rentz AM; Skalicky AM; Esser D; Zema C; Becker K; Bodhani A; Revicki DA
J Dermatolog Treat; 2020 Aug; 31(5):460-469. PubMed ID: 32045314
[No Abstract] [Full Text] [Related]
3. Psychometric properties of the Itch Numeric Rating Scale in patients with moderate-to-severe plaque psoriasis.
Kimball AB; Naegeli AN; Edson-Heredia E; Lin CY; Gaich C; Nikaï E; Wyrwich K; Yosipovitch G
Br J Dermatol; 2016 Jul; 175(1):157-62. PubMed ID: 26852717
[TBL] [Abstract][Full Text] [Related]
4. Psychometric validation of the Psoriasis Symptom Scale, Functional Assessment of Chronic Illness Therapy-Fatigue and pain-Visual Analogue Scale in patients with generalized pustular psoriasis.
Burden AD; Bissonnette R; Anatchkova M; Budhiarso I; Skalicky AM; Liberato ACS; Hu N; Thoma C; Gloede T; Kohlmann T; Lebwohl MG
J Eur Acad Dermatol Venereol; 2024 Jul; 38(7):1383-1390. PubMed ID: 38334243
[TBL] [Abstract][Full Text] [Related]
5. Measurement properties of a patient-reported outcome measure assessing psoriasis severity: The psoriasis symptoms and signs diary.
Mathias SD; Feldman SR; Crosby RD; Colwell HH; McQuarrie K; Han C
J Dermatolog Treat; 2016 Aug; 27(4):322-7. PubMed ID: 26634943
[TBL] [Abstract][Full Text] [Related]
6. Reliability and Validity of the Psoriasis Symptom Inventory in Patients With Psoriatic Arthritis.
Wilson HD; Mutebi A; Revicki DA; Mease PJ; Genovese MC; Erondu N; Nirula A; Yuan FJ; Viswanathan HN
Arthritis Care Res (Hoboken); 2015 Dec; 67(12):1750-6. PubMed ID: 26206134
[TBL] [Abstract][Full Text] [Related]
7. Validation of psychometric properties and development of response criteria for the psoriasis symptoms and signs diary (PSSD): results from a phase 3 clinical trial.
Armstrong A; Puig L; Langley R; Tsai TF; Song M; Wasfi Y; Jiang J; Li S; Han C
J Dermatolog Treat; 2019 Feb; 30(1):27-34. PubMed ID: 28797188
[TBL] [Abstract][Full Text] [Related]
8. Peak Pruritus Numerical Rating Scale: psychometric validation and responder definition for assessing itch in moderate-to-severe atopic dermatitis.
Yosipovitch G; Reaney M; Mastey V; Eckert L; Abbé A; Nelson L; Clark M; Williams N; Chen Z; Ardeleanu M; Akinlade B; Graham NMH; Pirozzi G; Staudinger H; Plaum S; Radin A; Gadkari A
Br J Dermatol; 2019 Oct; 181(4):761-769. PubMed ID: 30729499
[TBL] [Abstract][Full Text] [Related]
9. Qualitative analysis and reproducibility assessment of the Scalp Itch Numeric Rating Scale among patients with moderate to severe plaque psoriasis of the scalp.
Wang Y; Coyne K; Sofen H; Santanello N; Currie B; Zhang Z; Nograles K
J Dermatolog Treat; 2019 Dec; 30(8):775-783. PubMed ID: 30747550
[No Abstract] [Full Text] [Related]
10. Psychometric evaluation of the Symptoms of Infection with Coronavirus-19 (SIC): results from a cross-sectional study and a phase 3 clinical trial.
Chan EKH; Williams V; Romano C; Fehnel S; Slagle AF; Stoddard J; Sadoff J; Mayorga M; Lewis S; Yarr S; Ma J; Liu Y; Katz EG; McNulty P; van Dromme I; McQuarrie K
J Patient Rep Outcomes; 2023 May; 7(1):45. PubMed ID: 37195456
[TBL] [Abstract][Full Text] [Related]
11. Measurement Properties of the Psoriasis Symptom Inventory Electronic Daily Diary in Patients with Moderate to Severe Plaque Psoriasis.
Viswanathan HN; Mutebi A; Milmont CE; Gordon K; Wilson H; Zhang H; Klekotka PA; Revicki DA; Augustin M; Kricorian G; Nirula A; Strober B
Value Health; 2017 Sep; 20(8):1174-1179. PubMed ID: 28964451
[TBL] [Abstract][Full Text] [Related]
12. Development and psychometrics of the English version of the Itch Cognitions Questionnaire.
Heckman CJ; Schut C; Riley M; Ehlers A; Valdes-Rodriguez R; Kupfer J; Gieler U; Stapleton JL
PLoS One; 2020; 15(3):e0230585. PubMed ID: 32191772
[TBL] [Abstract][Full Text] [Related]
13. Psychometric Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM): A Novel Patient-Reported Outcome Instrument for Patients with Plaque Psoriasis, Using Reported Data from the BE RADIANT Phase 3b Trial.
Gottlieb AB; Warren RB; Augustin M; Garcia L; Cioffi C; Peterson L; Pelligra C; Ciaravino V
Adv Ther; 2021 Oct; 38(10):5253-5269. PubMed ID: 34471992
[TBL] [Abstract][Full Text] [Related]
14. Symptom Experience and Content Validity of the Psoriasis Symptom Scale (PSS) in Patients with Generalized Pustular Psoriasis (GPP).
Burden AD; Mrowietz U; Skalicky AM; Rentz AM; Esser D; Gloede T; Thoma C; Menter A
Dermatol Ther (Heidelb); 2022 Jun; 12(6):1367-1381. PubMed ID: 35590037
[TBL] [Abstract][Full Text] [Related]
15. Validation of the Psoriasis Symptom Inventory (PSI), a patient-reported outcome measure to assess psoriasis symptom severity.
Bushnell DM; Martin ML; McCarrier K; Gordon K; Chiou CF; Huang X; Ortmeier B; Kricorian G
J Dermatolog Treat; 2013 Oct; 24(5):356-60. PubMed ID: 23092173
[TBL] [Abstract][Full Text] [Related]
16. Reliability and validity of the psoriasis symptom inventory in patients with moderate-to-severe psoriasis.
Revicki DA; Jin Y; Wilson HD; Chau D; Viswanathan HN
J Dermatolog Treat; 2014 Feb; 25(1):8-14. PubMed ID: 23339373
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of the psoriasis scale among the system of quality of life instruments for chronic diseases QLICD-PS (V2.0).
Liu Q; Feng L; Wan C; Tan J; Yu J; Wang L
Health Qual Life Outcomes; 2022 Apr; 20(1):68. PubMed ID: 35459208
[TBL] [Abstract][Full Text] [Related]
18. Psychometric validation of the Psoriasis Symptom Diary using Phase III study data from patients with chronic plaque psoriasis.
Strober B; Zhao Y; Tran MH; Gnanasakthy A; Nyirady J; Papavassilis C; Nelson LM; McLeod LD; Mordin M; Gottlieb AB; Elewski BE; Lebwohl M
Int J Dermatol; 2016 Mar; 55(3):e147-55. PubMed ID: 26518255
[TBL] [Abstract][Full Text] [Related]
19. A disease-specific measure of health-related quality of life in adults with chronic immune thrombocytopenic purpura: psychometric testing in an open-label clinical trial.
Mathias SD; Bussel JB; George JN; McMillan R; Okano GJ; Nichol JL
Clin Ther; 2007 May; 29(5):950-962. PubMed ID: 17697914
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the psychometric properties of the St George's Respiratory Questionnaire in patients with severe asthma.
Nelsen LM; Vernon M; Ortega H; Cockle SM; Yancey SW; Brusselle G; Albers FC; Jones PW
Respir Med; 2017 Jul; 128():42-49. PubMed ID: 28610668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
